Background
Methods
Study population
POPULATION | OVERALL n = 127 | Group A N = 74 | Group B N = 53 | p-value |
---|---|---|---|---|
Age (years) | 55.2 ± 6.8 | 54.5 ± 6.8 | 56.3 ± 6.8 | 0.155 |
Gender (M/F) | 65/62 | 38/36 | 24/29 | 0.500 |
BMI (Kg/m2) | 29.2 ± 5.0 | 29.1 ± 5.1 | 29.5 ± 5.2 | 0.867 |
Diabetes duration (years)* | 3 (1-10)* | 3 (1-10)* | 3 (1-9) | 0.954 |
Smokers | 28 (22%) | 14 (19%) | 14 (26%) | 0.577 |
Ex-smokers | 40 (31%) | 25 (34%) | 15 (28%) | 0.504 |
Hypertension | 51 (40%) | 27 (37%) | 24 (45%) | 0.361 |
Hypercholesterolemia | 29 (23%) | 19 (26%) | 10 (19%) | 0.447 |
Creatinine (mg/dl) | 0.89 ± 0.21 | 0.87 ± 0.21 | 0.94 ± 0.21 | 0.115 |
Microalbuminuria | 34 (29%) | 18 (28%) | 16 (31%) | 0.666 |
LVEF (%) | 59.4 ± 4.8 | 60.5 ± 5.5 | 58.8 ± 3.7 | 0.143 |
LVMI (g/m2.7) | 43.7 ± 11.8 | 42.6 ± 12.1 | 45.2 ± 11.3 | 0.198 |
LVH | 51 (40%) | 27 (36%) | 24 (45%) | 0.361 |
Laboratory
Echocardiography
End-points
Statistics
Results
POPULATION | Group A n = 32 | Group B n = 22 | p-value |
---|---|---|---|
Age (years) | 52.6 ± 6.8 | 54.5 ± 8.4 | 0.355 |
Gender (M/F) | 17/15 | 9/13 | 0.377 |
BMI (Kg/m2) | 29.5 ± 5.1 | 30.2 ± 5.7 | 0.691 |
Diabetes duration (years)* | 4 (0.7-10) | 7 (3-10) | 0.225 |
Smokers | 6 (19%) | 8 (36%) | 0.303 |
Ex-smokers | 8 (25%) | 5 (23%) | 0.848 |
Hypertension | 7 (22%) | 8 (36%) | 0.243 |
Hypercholesterolemia | 8 (25%) | 5 (23%) | 0.848 |
Creatinine (mg/dl) | 0.90 ± 0.22 | 0.95 ± 0.24 | 0.407 |
Microalbuminuria | 33 (33%) | 30 (30%) | 1.000 |
LVEF (%) | 58.8 ± 5.2 | 58.9 ± 3.4 | 0.922 |
LVMI (g/m2.7) | 38.7 ± 9.8 | 40.9 ± 11.4 | 0.461 |
LVH | 4 (13%) | 6 (27%) | 0.170 |
HBA1C | 9.3 ± 1.6 | 9.4 ± 1.8 | 0.707 |
Insulin | 7 (22%) | 4 (18%) | 0.741 |
Oral antidiabetic agents | 18 (56%) | 15 (68%) | 0.377 |